GENE ONLINE|News &
Opinion
Blog

Biomarker
Australian Researchers Discover First Biomarker for Sudden Infant Death Syndrome
2022-05-18
Wearable Device for Measuring Multiple Biomarkers Anytime, Anywhere
2022-05-13
Israeli and South Korean Companies Collaborate in Drug Innovation with Data Platform
2022-04-19
How the IHMED Reproductive Center Improves Infertility Outcomes by Targeting Immune Response
2022-04-19Partner
AACR 2022: Roadmap to a Successful Biotech Start-up Journey
2022-04-16
How Patients with dMMR/MSI-H Tumors Can Benefit from Immunotherapy?
2021-09-24
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
Memorial Sloan Kettering AI spinout Partners with a Fortune 500 Company to Advance AI-powered Cancer Diagnosis
2021-05-28
M&A
Roche Forays into Syndromic Panel Testing by Placing $1.8 Billion Bet on GenMark Acquisition
2021-03-15
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
AACR 2020 Conference – Opening Clinical Plenary Highlights
2020-04-28
R&D
Gilead, Second Genome Partner to Explore Microbial Biomarkers
2020-04-08
QuarkBio Announces a COVID-19 Test Kit, 10 Times More Sensitive than Existing Kits
2020-03-24
Things you must know about the 10-minute universal cancer test
2018-12-11
1 2
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top